Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides

Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides

Obesity, diabetes, insulin resistance, sedentary lifestyle, and Western diet are the key factors underlying non-alcoholic fatty liver disease (NAFLD), one of the most common liver diseases in developed countries. In many cases, NAFLD further progresses to non-alcoholic steatohepatitis (NASH), fibros...

Full description

Bibliographic Details
Main Authors:	L. Kořínková, V. Pražienková, L. Černá, A. Karnošová, B. Železná, J. Kuneš, Lenka Maletínská
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-11-01
Series:	Frontiers in Endocrinology
Subjects:	peptides leptin glucagon-like peptide-1 ghrelin non-alcoholic steatohepatitis
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2020.597583/full

Similar Items

Prediction of early response to liraglutide therapy in patients with obesity
by: Oksana V. Logvinova, et al.
Published: (2020-06-01)

Prolactin-Releasing Peptide: Physiological and Pharmacological Properties
by: Veronika Pražienková, et al.
Published: (2019-10-01)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
by: Marta Seghieri, et al.
Published: (2018-11-01)

Pathophysiology of Non Alcoholic Fatty Liver Disease
by: Salvatore Petta, et al.
Published: (2016-12-01)

Central regulation of food intake, body weight, energy expenditure, and glucose homeostasis
by: Michael Murray Scott, et al.
Published: (2014-12-01)

Characteristics of eating behavior and the level of hormones regulating the appetite in patients with type 2 diabetes mellitus and body mass index more than 35 kg /m2
by: Ekaterina V. Tichonenko, et al.
Published: (2018-04-01)

Peptides and Food Intake
by: Carmen Sobrino Crespo, et al.
Published: (2014-04-01)

Preliminary results from digestive adaptation: a new surgical proposal for treating obesity, based on physiology and evolution
by: Sérgio Santoro, et al.

Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study
by: Alena Karnošová, et al.
Published: (2021-08-01)

Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity
by: Ekaterina V. Tikhonenko, et al.
Published: (2019-03-01)

South American herbal extracts reduce food intake through modulation of gastrointestinal hormones in overweight and obese women
by: Marina Monteiro Celestino, et al.
Published: (2017-08-01)

Correlation of lower 2 h C-peptide and elevated evening cortisol with high levels of depression in type 2 diabetes mellitus
by: Yu Ming Sang, et al.
Published: (2020-10-01)

Appetite and Gastrointestinal Hormone Response to a Gluten-Free Meal in Patients with Coeliac Disease
by: Paola Vitaglione, et al.
Published: (2019-01-01)

Associations of serum leptin, ghrelin and peptide YY levels with physical activity and cardiorespiratory fitness in adolescent boys with different BMI values
by: Liina Remmel, et al.
Published: (2017-12-01)

Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells
by: Anna Zmeškalová, et al.
Published: (2020-09-01)

Gastric Bypass in Morbid Obesity : Postoperative Changes in Metabolic, Inflammatory and Gut Regulatory Peptides
by: Holdstock, Camilla
Published: (2008)

Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH
by: Brian Finan, et al.
Published: (2021-04-01)

GLP-1 receptor agonists for NAFLD treatment in patients with and without type 2 diabetes: an updated meta-analysis
by: Alessandro Mantovani, et al.
Published: (2020-06-01)

The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study
by: Russo Francesco, et al.
Published: (2013-02-01)

Regulation of Appetite and Satiety by Gastrointestinal Peptides
by: Sarah H. Mhaibes, et al.
Published: (2021-06-01)

Profiles of peptide YY and ghrelin, levels of hunger and satiety, and ad libitum intake in obese and non-obese Indonesian women
by: Witjaksono Fiastuti, et al.
Published: (2019-03-01)

Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors
by: Jonas Ronn, et al.
Published: (2017-12-01)

Potential Role of Hypothalamic and Plasma Ghrelin in the Feeding Behavior of Obese Type 2 Diabetic Rats with Intraventricular Glucagon-Like Peptide-1 Receptor Agonist Intervention
by: Ke Lu, et al.
Published: (2020-12-01)

Ghrelin Is a Regulator of Glucagon-Like Peptide 1 Secretion and Transcription in Mice
by: Andreas Lindqvist, et al.
Published: (2017-06-01)

Treatment with Glucagon-Like Peptide-1 Analogues — a Breakthrough in Diabetes Mellitus Type 2 Therapy
by: V.L. Orlenko, et al.
Published: (2014-05-01)

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
by: Takaaki Murakami, et al.
Published: (2020-11-01)

The role of the microbiome in NAFLD and NASH
by: Aleksandra A Kolodziejczyk, et al.
Published: (2019-02-01)

The Interaction of Obesity and Ghrelin/Leptin
by: Aliye Sağkan Öztürk, et al.
Published: (2018-12-01)

Expression of Glucagon-Like Peptide 1 Receptor during Osteogenic Differentiation of Adipose-Derived Stem Cells
by: Yun Kyung Jeon, et al.
Published: (2014-12-01)

Hormones of Energy Metabolism in Critically Ill Foals: Insulin, Glucagon, Leptin, Adiponectin, Ghrelin and Growth Hormone
by: Barsnick, Rosa
Published: (2010)

The associations of incretin hormone concentration with gestational diabetes mellitus
by: Tatiana V. Saprina, et al.
Published: (2016-04-01)

New Potential Targets of Glucagon-Like Peptide 1 Receptor Agonists in Pancreatic β-Cells and Hepatocytes
by: Won-Young Lee
Published: (2017-02-01)

How Satiating Are the ‘Satiety’ Peptides: A Problem of Pharmacology versus Physiology in the Development of Novel Foods for Regulation of Food Intake
by: Jia Jiet Lim, et al.
Published: (2019-07-01)

DOES PALM MID FRACTION AFFECT ADULT SATIETY?
by: Lee, V.K.M, et al.
Published: (2021)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
by: Yu Mi Kang, et al.
Published: (2016-06-01)

Correlations of circulating peptide YY and ghrelin with body weight, rate of weight gain, and time required to achieve the recommended daily intake in preterm infants
by: XiaFang Chen, et al.
Published: (2012-07-01)

Correlations of circulating peptide YY and ghrelin with body weight, rate of weight gain, and time required to achieve the recommended daily intake in preterm infants
by: XiaFang Chen, et al.
Published: (2012-07-01)

Modulation of Neural Microcircuits That Control Complex Dynamics in Olfactory Networks
by: Zhenbo Huang, et al.
Published: (2021-06-01)

Noninvasive Diagnosis of NAFLD and NASH
by: Valeria Annarita Piazzolla, et al.
Published: (2020-04-01)

The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment
by: Baocheng Xie, et al.
Published: (2021-06-01)